产品
编 号：F762735
分子式：C32H29BrN2O10S3
分子量：777.68
分子式：C32H29BrN2O10S3
分子量：777.68
产品类型
规格
价格
是否有货
结构图
CAS No: 2977251-02-6
产品详情
生物活性：
HCVcc-IN-2 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. HCVcc-IN-2 has high inhibition against the three cell line from CNS cancer (SF-539 and SNB-75), colon cancer (HCT-116), and renal cancer (A498).
体外研究：
HCVcc-IN-2 (compound 6c) (0.1, 1, 10, and 100 μg/mL; 1 h) shows antiviral activities against a variety of viruses such as coxsackievirus B4 (CBV4), hepatitis A virus HM 175 (HAV), hepatitis C genotype 4 (HCVcc), adenovirus type 7 (HAdV7), and herpes simplex virus 1 (HSV-1) with viral reduction rates of 83.3%, 63.3%, 40%, 63.3%, and 30%, respectively. HCVcc-IN-2 (0.55-1.9 μg/mL; 1 h) inhibits various virus with IC50 of 0.55 μg/mL (herpes simplex virus), 0.76 μg/mL (HCVcc genotype virus), and 0.76 μg/mL (coxsackievirus B4), respectively; or with CC50 of 1.8 μg/mL (herpes simplex virus), 1.9 μg/mL (HCVcc genotype virus), and 1.9 μg/mL (coxsackievirus B4), respectively.HCVcc-IN-2 (7.68-16.01 μg/mL; ) inhibits hepatitis C virus NS3/4A and HSV- USP7 protease enzyme with IC50s of 16.01 μg/mL and 7.68 μg/mL.HCVcc-IN-2 (0.01 mM; 24 h) has low cytotoxicity, shows high inhibition against two cell lines, SK-MEL-5, OVCAR-4.
HCVcc-IN-2 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. HCVcc-IN-2 has high inhibition against the three cell line from CNS cancer (SF-539 and SNB-75), colon cancer (HCT-116), and renal cancer (A498).
体外研究：
HCVcc-IN-2 (compound 6c) (0.1, 1, 10, and 100 μg/mL; 1 h) shows antiviral activities against a variety of viruses such as coxsackievirus B4 (CBV4), hepatitis A virus HM 175 (HAV), hepatitis C genotype 4 (HCVcc), adenovirus type 7 (HAdV7), and herpes simplex virus 1 (HSV-1) with viral reduction rates of 83.3%, 63.3%, 40%, 63.3%, and 30%, respectively. HCVcc-IN-2 (0.55-1.9 μg/mL; 1 h) inhibits various virus with IC50 of 0.55 μg/mL (herpes simplex virus), 0.76 μg/mL (HCVcc genotype virus), and 0.76 μg/mL (coxsackievirus B4), respectively; or with CC50 of 1.8 μg/mL (herpes simplex virus), 1.9 μg/mL (HCVcc genotype virus), and 1.9 μg/mL (coxsackievirus B4), respectively.HCVcc-IN-2 (7.68-16.01 μg/mL; ) inhibits hepatitis C virus NS3/4A and HSV- USP7 protease enzyme with IC50s of 16.01 μg/mL and 7.68 μg/mL.HCVcc-IN-2 (0.01 mM; 24 h) has low cytotoxicity, shows high inhibition against two cell lines, SK-MEL-5, OVCAR-4.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备